Overview

Use of Acthar in Patients With FSGS That Will be Undergoing Renal Transplantation

Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
0
Participant gender:
All
Summary
This study will evaluate the use of Acthar in patients to undergo renal transplantation and will measure the rate of FSGS recurrence.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Georgetown University
University of Colorado, Denver
Treatments:
Adrenocorticotropic Hormone
Criteria
Inclusion Criteria:

- FSGS

- To receive either a live donor or deceased donor kidney transplant

Exclusion Criteria:

- Not having FSGS